{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:31:53Z","timestamp":1790227913426,"version":"4.1.0"},"reference-count":26,"publisher":"American Society for Clinical Investigation","issue":"6","funder":[{"name":"The Australian National Health & Medical Research Council project grants","award":["APP1068510,APP1113867,APP1017028"],"award-info":[{"award-number":["APP1068510,APP1113867,APP1017028"]}]},{"name":"The Australian National Health & Medical Research Council Practitioner Fellowship","award":["APP1105784"],"award-info":[{"award-number":["APP1105784"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,21]]},"abstract":"<jats:p>\n                    Anthracyclines are among the most effective chemotherapeutics ever developed, but they produce grueling side effects and serious adverse events, and resistance often develops over time. We found that these compounds can be sequestered by secreted cellular prion protein (PrP\n                    <jats:sup>C<\/jats:sup>\n                    ), which blocks their cytotoxic activity. This effect was dose dependent using either cell line\u2013conditioned medium or human serum as a source of PrP\n                    <jats:sup>C<\/jats:sup>\n                    . Genetic depletion of PrP\n                    <jats:sup>C<\/jats:sup>\n                    or inhibition of binding via chelation of ionic copper prevented the interaction and restored cytotoxic activity. This was more pronounced for doxorubicin than its epimer, epirubicin. Investigating the relevance to breast cancer management, we found that the levels of\n                    <jats:italic>PRNP<\/jats:italic>\n                    transcript in pretreatment tumor biopsies stratified relapse-free survival after neoadjuvant treatment with anthracyclines, particularly among doxorubicin-treated patients with residual disease at surgery. These data suggest that local sequestration could mediate treatment resistance. Consistent with this, tumor cell expression of PrP\n                    <jats:sup>C<\/jats:sup>\n                    protein correlated with poorer response to doxorubicin but not epirubicin in an independent cohort analyzed by IHC, particularly soluble isoforms released into the extracellular environment by shedding. These findings have important potential clinical implications for frontline regimen decision making. We suggest there is warranted utility for prognostic PrP\n                    <jats:sup>C<\/jats:sup>\n                    \/\n                    <jats:italic>PRNP<\/jats:italic>\n                    assays to guide chemosensitization strategies that exploit an understanding of PrP\n                    <jats:sup>C<\/jats:sup>\n                    -anthracycline-copper ion complexes.\n                  <\/jats:p>","DOI":"10.1172\/jci.insight.124092","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T12:01:34Z","timestamp":1551182494000},"source":"Crossref","is-referenced-by-count":17,"title":["Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer"],"prefix":"10.1172","volume":"4","author":[{"given":"Adrian P.","family":"Wiegmans","sequence":"first","affiliation":[{"name":"Tumor Microenvironment Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4604-4709","authenticated-orcid":true,"given":"Jodi M.","family":"Saunus","sequence":"additional","affiliation":[{"name":"Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunyoung","family":"Ham","sequence":"additional","affiliation":[{"name":"Tumor Microenvironment Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lobb","sequence":"additional","affiliation":[{"name":"Tumor Microenvironment Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5410-3636","authenticated-orcid":true,"given":"Jamie R.","family":"Kutasovic","sequence":"additional","affiliation":[{"name":"Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8362-6492","authenticated-orcid":true,"given":"Andrew J.","family":"Dalley","sequence":"additional","affiliation":[{"name":"Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariska","family":"Miranda","sequence":"additional","affiliation":[{"name":"Personalized Medicine Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Atkinson","sequence":"additional","affiliation":[{"name":"Children\u2019s Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, New South Wales, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7450-6926","authenticated-orcid":true,"given":"Simote T.","family":"Foliaki","sequence":"additional","affiliation":[{"name":"Department of Medicine (Royal Melbourne Hospital), The University of Melbourne, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaltin","family":"Ferguson","sequence":"additional","affiliation":[{"name":"Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Niland","sequence":"additional","affiliation":[{"name":"Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6464-8661","authenticated-orcid":true,"given":"Cameron N.","family":"Johnstone","sequence":"additional","affiliation":[{"name":"Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Medicine (Royal Melbourne Hospital), The University of Melbourne, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Collins","sequence":"additional","affiliation":[{"name":"Department of Medicine (Royal Melbourne Hospital), The University of Melbourne, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil R.","family":"Lakhani","sequence":"additional","affiliation":[{"name":"Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia."},{"name":"Pathology Queensland, The Royal Brisbane and Women\u2019s Hospital, Herston, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1553-0077","authenticated-orcid":true,"given":"Fares","family":"Al-Ejeh","sequence":"additional","affiliation":[{"name":"Personalized Medicine Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"M\u00f6ller","sequence":"additional","affiliation":[{"name":"Tumor Microenvironment Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2019,3,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00079-0"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.10-10-780"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.4147"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-015-2022-z"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3398"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-011-9325-9"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm406"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nature10983"},{"issue":"5","key":"B9","article-title":"Functional and genomic characterisation of a xenograft model system for the study of metastasis in triple-negative breast cancer","volume":"11","author":"Johnstone","year":"2018","journal-title":"Dis Model Mech"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308413101"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153931"},{"issue":"7","key":"B12","first-page":"2507","article-title":"Doxorubicin and congo red effectiveness on prion infectivity in golden Syrian hamster","volume":"29","author":"Corato","year":"2009","journal-title":"Anticancer Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117286"},{"issue":"4","key":"B14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/BF00685539","article-title":"Comparative pharmacokinetics of doxorubicin given by three different schedules with equal dose intensity in patients with breast cancer","volume":"28","author":"Twelves","year":"1991","journal-title":"Cancer Chemother Pharmacol"},{"issue":"7","key":"B15","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22071106","article-title":"Newly synthesized doxorubicin complexes with selected metals-synthesis, structure and anti-breast cancer activity","volume":"22","author":"Jab\u0142o\u0144ska-Trypu\u0107","year":"2017","journal-title":"Molecules"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1021\/ar0301678"},{"issue":"1","key":"B17","first-page":"53","article-title":"Chelation of copper(II) ions by doxorubicin and 4\u2019-epidoxorubicin: an e.s.r. study","volume":"1","author":"Malatesta","year":"1985","journal-title":"Anticancer Drug Des"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.032599"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2008.10.012"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/19336896.2015.1110293"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-013-9420-1"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.5.2042"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-2980.2011.00563.x"},{"issue":"1","key":"B24","first-page":"BC25","article-title":"Serum levels of metal ions in female patients with breast cancer","volume":"9","author":"Pavithra","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"B25","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v1i0.18514","article-title":"The launch of Journal of Extracellular Vesicles (JEV), the official journal of the International Society for Extracellular Vesicles - about microvesicles, exosomes, ectosomes and other extracellular vesicles","volume":"1","author":"L\u00f6tvall","year":"2012","journal-title":"J Extracell Vesicles"},{"key":"B26","doi-asserted-by":"crossref","unstructured":"McCart Reed AE, Saunus JM, Ferguson K, Niland C, Simpson PT, and Lakhani SR. The Brisbane Breast Bank. Open Journal of Bioresources Web site. https:\/\/openbioresources.metajnl.com\/articles\/10.5334\/ojb.33\/ Accessed February 18, 2019","DOI":"10.5334\/ojb.33"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/124092\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:32:42Z","timestamp":1779193962000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/124092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,21]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,3,21]]},"published-print":{"date-parts":[[2019,3,21]]}},"alternative-id":["10.1172\/jci.insight.124092"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.124092","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,21]]},"article-number":"e124092"}}